Showing results (491-500 of 804) with videos related to

Sort By:
Pageof 81
Neurologia|November 9, 2021
Spanish expert consensus on the use of safinamide in Parkinson's diseaseF Valldeoriola, F Grandas, J M Arbelo, et al.
Neurologia|November 9, 2021
Analysis of cognitive performance and polymorphisms of SORL1, PVRL2, CR1, TOMM40, APOE, PICALM, GWAS_14q, CLU, and BIN1 in patients with mild cognitive impairment and cognitively healthy controlsF Cruz-Sanabria, K Bonilla-Vargas, K Estrada, et al.
Neurologia|November 9, 2021
Perception of the validity of the Migraine Disability Assessment questionnaire in a population of patients with chronic migraineV Medrano Martínez, I Francés Pont, L Hernández Rubio, et al.
Neurologia|March 15, 2021
Parkinson's disease: An update on preclinical studies of induced pluripotent stem cellsV Valadez-Barba, K Juárez-Navarro, E Padilla-Camberos, et al.
Neurologia|March 16, 2021
Effect of botulinum toxin typeA in functionality, synkinesis and quality of life in peripheral facial palsy sequelaeU Díaz-Aristizabal, M Valdés-Vilches, T R Fernández-Ferreras, et al.
Neurologia|October 22, 2022
Barcelona scale for buccophonatory apraxia: Quantitative assessment toolN Montagut, S Borrego-Écija, J Herrero, et al.
Neurologia|October 4, 2022
Is there a halo-enzymopathy in Parkinson's disease?E Fernández-Espejo
Neurologia|July 27, 2019
The role of vagus nerve stimulation in the treatment of refractory epilepsy: Clinical outcomes and impact on quality of lifeC Martorell-Llobregat, P González-López, E Luna, et al.
Neurologia|September 5, 2022
Gadolinium-enhanced brain lesions in multiple sclerosis relapseL Martín-Aguilar, S Presas-Rodriguez, À Rovira, et al.
Neurologia|May 5, 2019
Attention to acute cerebrovascular disease in Guipúzcoa: Description of the results of a reference hospital in a centralized care modelG Fernández-Eulate, P Arocena, A Muñoz-Lopetegi, et al.
Pageof 81